A selective, reversible, competitive inhibitor of monoamine oxidase A containing no nitrogen, with negligible potentiation of tyramine-induced blood pressure rise.
Harfenist
M
M
Division of Organic Chemistry, Burroughs Wellcome Co., Research Triangle Park North Carolina 27709.
McGee
D P
DP
White
H L
HL
D000818:Animals; D001667:Binding, Competitive; D001794:Blood Pressure / Q000187:drug effects*; D001921:Brain / Q000201:enzymology; D006571:Heterocyclic Compounds / Q000494:pharmacology*; D008996:Monoamine Oxidase Inhibitors / Q000737:chemistry / Q000494:pharmacology*; D009584:Nitrogen / Q000737:chemistry*; D010084:Oxidation-Reduction; D051381:Rats; D014439:Tyramine / Q000494:pharmacology*
D006571:Heterocyclic Compounds; D008996:Monoamine Oxidase Inhibitors; C068135:phenoxathiin; D009584:Nitrogen; D014439:Tyramine